Members
박사 후 과정
Yang, Hee Doo
in Ph.D. Course
02-2258-7448
주요연구분야 : 신규한 긴가닥 비번역 RNA (novel lncRNA)에 의한 간암발생기전연구
Iso-miRNA의 신규 타겟 유전자에 의한 간암발생기전연구
Publication
-
Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development.
Yang HD, Nam SW
Exp Mol Med. 2020 Apr (accepted), review
IF: 4.743
-
HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
Yang HD, Kim HS, Kim SY, Na MJ, Yang G, Eun JW, Wang HJ, Cheong JY, Park WS, Nam SW.
Hepatology. 2019 Oct;70(4):1262-1279. doi: 10.1002/hep.30657.
IF: 14.971
Yang HD*, Eun JW*, Lee KB*, Shen Q, Kim HS, Kim SY, Seo DW, Park WS, Lee JY, Nam SW.
Exp Mol Med. 2018 Jan 5;50(1):e420. doi: 10.1038/emm.2017.166. *Equally contributed
IF: 4.743
Yang HD*, Kim PJ*, Eun JW, Shen Q, Kim HS, Shin WC, Ahn YM, Park WS, Lee JY, Nam SW.
Oncotarget. 2016 Mar 8;7(10):11412-23. doi: 10.18632/oncotarget.7194. *Equally contributed
IF: 5.168
Patents
-
2019 간암의 예방 또는 치료용 조성물 (국내특허 출원 10-2019-0041829)
-
2019 간암의 재발 및 예후 예측용 TCIRG1 마커 및 이의 용도 (국내특허 등록 10-2042332-0000)
-
2018 신규한 간암 치료제 타겟으로서 H2AZ.1의 용도 (국내특허 등록10-1927577-0000)
-
2017 Use of H2A.Z.1 as a hepatocellular carcinoma biomarker (미국특허 출원15/408987)
박사 과정
Kim, Sang Yean
Publication
-
Characteristic molecular signature of pericardial effucion identifies malignant cancer in pericardial disorder patients
Kim SY, Eun JW, Kim HS, Yang HD, Na MJ, Ahn YM, Jung HO, Nam SW.
Molecular & Cellular Toxicology. 2020.
IF: 1.830
-
SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
Kim SY, Shen Q, Son K, Kim HS, Yang HD, Na MJ, Shin E, Yu S, Kang K, You JS, Yu KR, Jeong SM, Lee EK, Ahn YM, Park WS, Nam SW.
Oncogene. 2021 Jul;40(28):4652-4662. doi: 10.1038/s41388-021-01875-6. Epub 2021 Jun 17.
Na, Min Jeong
Publication
-
석사 과정
Shin, Eun Bi
in M.S Course
02-2258-7448
주요연구분야 : 선택적 3`폴리아데틸화 (Alternative polyadenylation, APA) 에 의한 간암발생기전연구
